These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26511815)

  • 21. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
    Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
    BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain.
    Velázquez Rivera I; Muñoz Garrido JC; García Velasco P; España Ximénez de Enciso I; Velázquez Clavarana L
    Adv Ther; 2014 Jan; 31(1):107-17. PubMed ID: 24385406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
    Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies.
    Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Ficorella C; Raineri M; Giarratano A; Casuccio A
    Curr Med Res Opin; 2013 Jun; 29(6):667-71. PubMed ID: 23551065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment.
    Reis-Pina P; Acharya A; Barbosa A; Lawlor PG
    Pain Res Manag; 2020; 2020():6190862. PubMed ID: 32566062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
    Boceta J; De la Torre A; Samper D; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2016 Nov; 18(11):1088-1097. PubMed ID: 26856600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets.
    Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ; Sanz A
    Drugs R D; 2019 Sep; 19(3):247-254. PubMed ID: 31177479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A European survey of oncology nurse breakthrough cancer pain practices.
    Rustøen T; Geerling JI; Pappa T; Rundström C; Weisse I; Williams SC; Zavratnik B; Kongsgaard UE; Wengström Y
    Eur J Oncol Nurs; 2013 Feb; 17(1):95-100. PubMed ID: 22742829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cultural adaptation and psychometric validation of the Portuguese breakthrough pain assessment tool with cancer patients.
    Bernardes SF; Matos M; Mourão S; Vauclair CM
    Scand J Pain; 2021 Oct; 21(4):688-695. PubMed ID: 33930265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of individualized management of breakthrough cancer pain on quality of life in advanced cancer patients: CAVIDIOPAL study.
    Tuca Rodríguez A; Núñez Viejo M; Maradey P; Canal-Sotelo J; Guardia Mancilla P; Gutiérrez Rivero S; Raja Casillas I; Herrera Abián M; López Bermudo C
    Support Care Cancer; 2021 Aug; 29(8):4799-4807. PubMed ID: 33533986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study.
    Mercadante S; Aielli F; Adile C; Costanzi A; Casuccio A
    J Pain Symptom Manage; 2016 Jul; 52(1):27-34. PubMed ID: 27208863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 34. Breakthrough cancer pain in 2020.
    Løhre ET; Thronæs M; Klepstad P
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):94-99. PubMed ID: 32332210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How nurses assess breakthrough cancer pain, and the impact of this pain on patients' daily lives--results of a European survey.
    Rustøen T; Geerling JI; Pappa T; Rundström C; Weisse I; Williams SC; Zavratnik B; Wengström Y
    Eur J Oncol Nurs; 2013 Aug; 17(4):402-7. PubMed ID: 23276599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management
.
    Brant JM; Rodgers BB; Gallagher E; Sundaramurthi T
    Clin J Oncol Nurs; 2017 Jun; 21(3 Suppl):71-80. PubMed ID: 28524907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures.
    Pardo J; Mena A; Jiménez E; Aymar N; Ortiz I; Roncero R; Mestre F; Vidal M
    Clin Transl Oncol; 2019 Nov; 21(11):1568-1572. PubMed ID: 31093890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough cancer pain: twenty-five years of study.
    Mercadante S; Portenoy RK
    Pain; 2016 Dec; 157(12):2657-2663. PubMed ID: 27653423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature.
    Deandrea S; Corli O; Consonni D; Villani W; Greco MT; Apolone G
    J Pain Symptom Manage; 2014 Jan; 47(1):57-76. PubMed ID: 23796584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain.
    Tagami K; Okizaki A; Miura T; Watanabe YS; Matsumoto Y; Morita T; Fujimori M; Kinoshita H
    J Palliat Med; 2018 Nov; 21(11):1636-1640. PubMed ID: 29975582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.